PMID- 23602387 OWN - NLM STAT- MEDLINE DCOM- 20130627 LR - 20211021 IS - 1878-1551 (Electronic) IS - 1534-5807 (Print) IS - 1534-5807 (Linking) VI - 25 IP - 2 DP - 2013 Apr 29 TI - Endosomal type Igamma PIP 5-kinase controls EGF receptor lysosomal sorting. PG - 144-55 LID - S1534-5807(13)00159-7 [pii] LID - 10.1016/j.devcel.2013.03.010 [doi] AB - Endosomal trafficking and degradation of epidermal growth factor receptor (EGFR) play an essential role in the control of its signaling. Phosphatidylinositol-4,5-bisphosphate (PtdIns4,5P(2)) is an established regulator of endocytosis, whereas PtdIns3P modulates endosomal trafficking. However, we demonstrate here that type I gamma phosphatidylinositol phosphate 5-kinase i5 (PIPKIgammai5), an enzyme that synthesizes PtdIns4,5P(2), controls endosome-to-lysosome sorting of EGFR. In this pathway, PIPKIgammai5 interacts with sorting nexin 5 (SNX5), a protein that binds PtdIns4,5P(2) and other phosphoinositides. PIPKIgammai5 and SNX5 localize to endosomes, and loss of either protein blocks EGFR sorting into intraluminal vesicles (ILVs) of the multivesicular body. Loss of ILV sorting greatly enhances and prolongs EGFR signaling. PIPKIgammai5 and SNX5 prevent Hrs ubiquitination, and this facilitates the Hrs association with EGFR that is required for ILV sorting. These findings reveal that PIPKIgammai5 and SNX5 form a signaling nexus that controls EGFR endosomal sorting, degradation, and signaling. CI - Copyright (c) 2013 Elsevier Inc. All rights reserved. FAU - Sun, Yue AU - Sun Y AD - University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53706, USA. FAU - Hedman, Andrew C AU - Hedman AC FAU - Tan, Xiaojun AU - Tan X FAU - Schill, Nicholas J AU - Schill NJ FAU - Anderson, Richard A AU - Anderson RA LA - eng GR - CA104708/CA/NCI NIH HHS/United States GR - T32 GM008688/GM/NIGMS NIH HHS/United States GR - T32 GMGM08688/PHS HHS/United States GR - R01 CA104708/CA/NCI NIH HHS/United States GR - P30 CA014520/CA/NCI NIH HHS/United States GR - HHMI/Howard Hughes Medical Institute/United States GR - R01 GM057549/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130418 PL - United States TA - Dev Cell JT - Developmental cell JID - 101120028 RN - 0 (Phosphatidylinositol 4,5-Diphosphate) RN - 0 (RNA, Small Interfering) RN - 0 (SNX5 protein, human) RN - 0 (Sorting Nexins) RN - EC 2.7.1.- (Phosphotransferases (Alcohol Group Acceptor)) RN - EC 2.7.1.68 (1-phosphatidylinositol-4-phosphate 5-kinase) RN - EC 2.7.10.1 (EGFR protein, human) RN - EC 2.7.10.1 (ErbB Receptors) SB - IM MH - Amino Acid Sequence MH - Blotting, Western MH - Breast Neoplasms/*metabolism/pathology MH - Endocytosis/physiology MH - Endosomes/*metabolism MH - Enzyme-Linked Immunosorbent Assay MH - ErbB Receptors/genetics/*metabolism MH - Female MH - Flow Cytometry MH - Fluorescent Antibody Technique MH - Humans MH - Immunoenzyme Techniques MH - Immunoprecipitation MH - Lysosomes/*metabolism MH - Molecular Sequence Data MH - Phosphatidylinositol 4,5-Diphosphate/*metabolism MH - Phosphotransferases (Alcohol Group Acceptor)/antagonists & inhibitors/genetics/*metabolism MH - Protein Binding MH - Protein Transport MH - Proteolysis MH - RNA, Small Interfering/genetics MH - Signal Transduction MH - Sorting Nexins/genetics/*metabolism MH - Tumor Cells, Cultured MH - Two-Hybrid System Techniques MH - Ubiquitination PMC - PMC3740164 MID - NIHMS459779 COIS- The authors declare no competing financial interests. EDAT- 2013/04/23 06:00 MHDA- 2013/06/29 06:00 PMCR- 2014/04/29 CRDT- 2013/04/23 06:00 PHST- 2012/07/29 00:00 [received] PHST- 2013/01/24 00:00 [revised] PHST- 2013/03/15 00:00 [accepted] PHST- 2013/04/23 06:00 [entrez] PHST- 2013/04/23 06:00 [pubmed] PHST- 2013/06/29 06:00 [medline] PHST- 2014/04/29 00:00 [pmc-release] AID - S1534-5807(13)00159-7 [pii] AID - 10.1016/j.devcel.2013.03.010 [doi] PST - ppublish SO - Dev Cell. 2013 Apr 29;25(2):144-55. doi: 10.1016/j.devcel.2013.03.010. Epub 2013 Apr 18.